Provided by Tiger Trade Technology Pte. Ltd.

Chemours

15.03
-0.0400-0.27%
Post-market: 15.220.1900+1.26%19:30 EDT
Volume:1.18M
Turnover:17.81M
Market Cap:2.25B
PE:-7.44
High:15.28
Open:15.22
Low:14.98
Close:15.07
52wk High:28.67
52wk Low:10.44
Shares:149.89M
Float Shares:148.93M
Volume Ratio:0.72
T/O Rate:0.79%
Dividend:0.35
Dividend Rate:2.33%
EPS(TTM):-2.0200
EPS(LYR):-2.5700
ROE:-319.37%
ROA:1.42%
PB:-45.98
PE(LYR):-5.85

Loading ...

Chemours to pay $450M to settle DOJ, EPA, WV DEP claims

TIPRANKS
·
Jun 24

U.S. Justice Dept Says Chemours Agrees to $450M Settlement Agreement for Releases of Pfas in West Virginia, North Carolina, and New Jersey

THOMSON REUTERS
·
Jun 24

Truist Financial Reaffirms Their Buy Rating on Chemours Company (CC)

TIPRANKS
·
Jun 18

Grayscale pursues Canton Coin ETF after Hyperliquid debut

cryptonews
·
Jun 05

SEALSQ's QS7001 Post-Quantum Secure Element Achieves NIST SP 800-90B Entropy Source Validation, key milestone Toward FIPS 140-3 and Common Criteria EAL5+ Certification

GlobeNewswire
·
May 28

Worldcoin leads top-100 crypto gainers as Zcash slides 10%

cryptonews
·
May 27

Chemours (CC) Valuation In Focus As EPA Eases Refrigerant Rules And Policy Support Shifts

Simply Wall St.
·
May 25

Chemours Is Maintained at Neutral by JP Morgan

Dow Jones
·
May 22

Chemours Lawsuit Dismissed as Court Finds Investors Failed to Plead Misleading Statements

TIPRANKS
·
May 22

Chemours price target raised to $22 from $17 at JPMorgan

TIPRANKS
·
May 21

Three reasons why Canton price could surge past $0.18

cryptonews
·
May 14

Chemours Reiterated 2026 Guidance but Investors Wanted Stronger Signal, RBC Says

MT Newswires Live
·
May 12

Chemours Is Maintained at Outperform by RBC Capital

Dow Jones
·
May 12

Chemours price target raised to $21 from $17 at Morgan Stanley

TIPRANKS
·
May 11

Stock Track | Chemours Soars 5.03% in Early Trading After RBC Capital Raises Price Target to $29

Stock Track
·
May 11

Chemours price target raised to $29 from $26 at RBC Capital

TIPRANKS
·
May 11

RBC Capital Adjusts Chemours Price Target to $29 From $26, Maintains Outperform Rating

MT Newswires Live
·
May 11

Does Chemours' (CC) Q1 Beat And Dividend Hint At A Shift In Capital Priorities?

Simply Wall St.
·
May 10

Chemours Is Maintained at Buy by UBS

Dow Jones
·
May 09

Chemours price target raised to $30 from $29 at UBS

TIPRANKS
·
May 09